Excelestar Ventures

Adona Medical is a privately held portfolio company of Shifamed that innovates interventional approaches for heart failure, a complex and progressive condition impacting approximately 6.5 million patients in the US and as many as 26 million patients globally. Adona's platform will overcome the shortcomings of existing treatment options and enable providers to improve care for heart failure patients.

Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directly discovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering.

Instylla’s focus is to leverage hydrogel technology .

Terecircuits Corporation specializes in the development of materials and processes that facilitate microassembly and mass transfer for displays and advanced electronics. Founded in 2015 and based in Mountain View, California, the company provides a range of advanced polymers, encapsulation materials, and liquid metal interconnects. Its innovations include photo-polymer mass transfer technology specifically designed for MicroLED applications in sectors such as automotive and augmented/virtual reality. Additionally, Terecircuits offers new materials and design frameworks for systems in package manufacturing, targeting the Internet of Things and health technology markets. By serving the display, electronics, and semiconductor industries, Terecircuits enables the creation of low-cost, lightweight, and energy-efficient products, allowing manufacturers to produce IoT devices more efficiently and accurately.

Adona Medical is a privately held portfolio company of Shifamed that innovates interventional approaches for heart failure, a complex and progressive condition impacting approximately 6.5 million patients in the US and as many as 26 million patients globally. Adona's platform will overcome the shortcomings of existing treatment options and enable providers to improve care for heart failure patients.

Kinnos Inc., founded in 2014 and based in Brooklyn, New York, specializes in innovative solutions for infectious disease decontamination. The company's flagship product, Highlight, is a patent-pending powdered additive that enhances disinfectants by providing real-time color-change feedback, ensuring thorough cleaning and improving compliance among users. Highlight is utilized internationally by hospitals, first responders, and humanitarian agencies, facilitating effective disinfection of surfaces and clothing. In addition to the Highlight powder, Kinnos offers Highlight Wipes and a dispensing machine, further supporting its mission to protect society from infections and prevent disease outbreaks.

Kinnos Inc., founded in 2014 and based in Brooklyn, New York, specializes in innovative solutions for infectious disease decontamination. The company's flagship product, Highlight, is a patent-pending powdered additive that enhances disinfectants by providing real-time color-change feedback, ensuring thorough cleaning and improving compliance among users. Highlight is utilized internationally by hospitals, first responders, and humanitarian agencies, facilitating effective disinfection of surfaces and clothing. In addition to the Highlight powder, Kinnos offers Highlight Wipes and a dispensing machine, further supporting its mission to protect society from infections and prevent disease outbreaks.

Conformal Medical, Inc. is a medical device company focused on developing innovative solutions to prevent strokes in patients with atrial fibrillation (AFib), particularly those with non-valvular AFib. Founded in 2016 and headquartered in Nashua, New Hampshire, the company offers CLAAS Technology, which facilitates the sealing of the left atrial appendage (LAA) through its conformal left atrial appendage closure (LAAC) system. This proprietary technology is designed to adapt to the unique anatomy of each patient, enhancing the effectiveness of LAA closure procedures. By enabling healthcare professionals to treat patients at risk of stroke more effectively, Conformal Medical aims to improve clinical outcomes and save lives.

Lantos Technologies, Inc. specializes in 3D digital ear scanning technology that facilitates the creation of personalized in-ear devices. The company offers the AURA 3D ear scanning system, which is utilized for designing in-ear headphones, musicians' monitors, hearing aids, and noise protection solutions. Lantos Technologies is recognized for having the only FDA-cleared 3D ear scanning system, which enhances the quality and efficiency of custom ear products by capturing detailed measurements from the outer ear to the second bend of the ear canal. Founded in 2009 and based in Derry, New Hampshire, the company was formerly known as Lantos 2.0 Inc. before rebranding in December 2020.

Diesel Labs, Inc. is a mobile video analytics company based in Boston, Massachusetts, founded in 2016. The company specializes in empowering marketers to enhance their television ad campaigns by translating them into targeted mobile video campaigns. Utilizing proprietary technology and advanced machine learning techniques, Diesel Labs analyzes media consumption and engagement data to enable clients to effectively target audiences based on their viewing habits across various platforms, including short-form videos and premium streaming content. By leveraging social media analytics, Diesel Labs facilitates coordinated cross-channel messaging, streamlining the media planning process and helping clients make informed marketing, programming, and sales decisions. The team at Diesel Labs comprises experienced professionals, including former senior members from Bluefin Labs, a notable social TV analytics firm.

Altiostar Networks, Inc. specializes in designing and developing solutions for mobile network operators, focusing on enhancing LTE network coverage and capacity. The company offers a range of products, including macro iRRH radios suitable for various outdoor environments and small cell iRRHs aimed at improving network capacity in densely populated urban areas. Altiostar's innovative approach includes software that supports open interfaces and virtualizes baseband units, facilitating the creation of disaggregated, multi-vendor, cloud-native mobile networks. Founded in 2011 and based in Tewksbury, Massachusetts, Altiostar aims to enhance communication experiences while reducing technology costs for its clients.

Anova Data is an end-to-end 360-degree analytics framework to radically shift an operator’s position from reactive to proactive. The framework delivers out-of-the-box analytics applications allowing the operator to realize the untapped potential of network assets across a number of functions such as marketing, monetization, customer care, network assurance, and end-to-end service orchestration. Anova’s web-scale, end-to-end analytics solutions unleash the full value of subscriber and network data insight, enabling operators to get ahead of unprecedented subscriber data growth and take back control of their networks. Anova Data was founded in 2015 and is headquartered in Westford, Massachusetts.

SpaceOAR is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Its hydrogel is clinically proven to minimize side effects and protect the quality of life for prostate cancer patients undergoing radiation therapy that enables healthcare providers to minimize urinary, sexual, and bowel side effects of the patients. It was founded in 2007 and is headquartered in Bedford, Massachusetts.

Zettics specializes in mobile analytics and measurement applications, providing operators with comprehensive insights into data usage. The company’s solutions enable operators to enhance subscriber relationships, comply with privacy policies, and monetize data through partnerships with third parties. Zettics' tools allow for the analysis of trends in data usage, enrichment of customer relationship management systems, identification of network abuse, and evaluation of pricing plans. Additionally, they facilitate improved advertising offers, reduction of subscriber churn, and forecasting of network usage growth. With a portfolio of over 60 use cases, Zettics delivers substantial return on investment for operators by offering real-time visibility and analytics across various applications, including video and messaging.

Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, founded in 2008. The company specializes in developing diagnostic tests aimed at predicting a woman's individualized risk of premature birth, preeclampsia, and other pregnancy-related complications. By utilizing proprietary biomarkers, Sera Prognostics seeks to address the significant economic and healthcare challenges associated with premature births, impacting infants, families, and society at large. The company has licensed advanced serum proteomics technology and innovative peptides from Brigham Young University and the University of Utah to support its research and development efforts.